Feature Article: Aluminum and Asthma?
Published on
Parents PACKPublished on
Parents PACKWhen it’s time to decide about vaccines for their children, parents are often wrought with angst. They want to protect their children and do “the right thing,” but they worry that vaccination could inadvertently harm the child. These fears are often made worse if a parent seeks out information on the internet or social media. Indeed, even in casual conversations with other parents, vaccine safety concerns may be magnified.
Often the most concerning ideas are those that are vague; for example, the notion that vaccines are replacing infectious diseases with chronic diseases. This idea is validated in parents’ minds by the fact that they have never seen or experienced the infectious disease that the vaccine is aimed at, but they have seen or experienced the chronic condition being put forth as an example.
Asthma is one such example. Asthma is a chronic condition in which airways in the lungs suffer prolonged, low-level inflammation, causing the individual to have periodic episodes of breathing difficulties and wheezing when the inflammation is aggravated.
While the causes of asthma continue to be studied, several factors are known to contribute to the likelihood of developing this condition. These include family history, other allergies, infections during childhood that are caused by certain respiratory viruses, exposure to particular environmental conditions (e.g., dust, mites, smoke, chemicals, molds and smog), and obesity.
Recently, a paper was published that suggested a potential association between the amount of aluminum children were exposed to in vaccines during the first two years of life and their likelihood of being diagnosed with asthma between 2 and 5 years of age. Like concerns about vaccines causing chronic conditions, concerns about aluminum in vaccines have been around for some time, which is why these researchers completed the study. Because of this interest, we wanted to work through these findings together with our readers.
Daley MF, Reifler LM, Glanz JM, et al. Association between aluminum exposure from vaccines before age 24 months and persistent asthma at age 24-59 months. Acad Peds. 2022, Article in press.
This study analyzed data from the Vaccine Safety Datalink (VSD), a U.S.-based research network designed to monitor vaccinations for the purposes of vaccine safety. Three aspects of this study are worth looking at more closely to understand what it does and does not tell us about aluminum and asthma: study population, aluminum processing, and disease caused by aluminum.
The study population included 326,991 children born between January 2008 and December 2014 who received care from one of seven VSD sites. Of these, 7,546 were identified as having asthma based on the study definition. For each child, immunization records were used to determine their aluminum exposure from vaccines during the first two years of life with the goal of comparing that exposure with the likelihood of developing asthma between 3 and 5 years of age. Two population-based choices made by the researchers are important given the goals of this study:
As a result of these two choices, more than 6% of children (n = 25,188) were excluded from the study sample (because they were diagnosed with asthma before 24 months of age) and more than 4% (n = 14,337) were separated and compared with the remaining cohort (because they were diagnosed with eczema before 12 months of age). Given the number of children excluded because they developed asthma prior to “completing” their exposure to aluminum, we need to be cautious about our interpretation of these data, particularly as related to causality. It is notable that more children were excluded because they had the condition being studied than children in the subgroup considered to be at increased risk for developing the condition.
The goal of this study was to evaluate exposure to aluminum and development of asthma. However, this aspect of the study also has important considerations to keep in mind when considering the findings:
By opting to evaluate exposure to aluminum based solely on vaccine content in the first two years of life, the study established an arbitrary assumption. And, while one could argue that this was a low threshold to which all children were exposed, we have no information about the other quantities to which children were exposed. The authors tried to evaluate breastfeeding during the first two years of life, but the data were limited, and there was no information related to which formulas the non-breastfed infants were fed (aluminum concentrations vary by product and preparation), daily volumes they consumed, etc. The authors also failed to control for exposure to environmental pollutants or a family history of asthma or allergies. This critical lack of controls severely limited the authors’ ability to isolate the effect of the one variable they were interested in studying — aluminum intake. Additionally, all participants continued to consume food and water during years three to five, when they were diagnosed, and here too, there were no data to evaluate their exposures. In short, while it is difficult to assess the effects of exposure in a situation like this, applying arbitrary assumptions that exclude ongoing exposures and biological processing variability does not really help us understand anything about the association between these two variables.
Aluminum-containing ingredients are included in some vaccines because they serve as adjuvants, which are ingredients that increase the immune response to a vaccine. The authors theorized that the aluminum content in vaccines could change the type of immune response generated by the vaccine (T helper 1 (Th1) vs T helper 2 (Th2)). Because the latter (Th2) induces chemicals that cause low levels of inflammation, they hypothesized that a disease based on long-term inflammation, like asthma, was theoretically possible. While understanding the mechanism by which an adjuvant increases the immune response is an important undertaking, the type of study the authors undertook will not answer that question. Further, if we evaluate the larger context, some observations are important:
For these reasons, an analysis to understand the hypothesis that an adjuvant changes the way the vaccine is processed would be better answered using alternative research approaches.
The primary conclusion these authors presented was that “a positive association was found between vaccine-related aluminum exposure and persistent asthma.”
Unfortunately, this primary conclusion fails to provide additional context:
Likewise, as described earlier, choices made in designing this study can’t be dismissed because the real world does not operate in closed systems. Deciding to only look at aluminum delivered by vaccines while ignoring the everyday exposures from other sources is not representative of what happens. Further, using cumulative measures of aluminum introduced by vaccines as if they are static over a four- to five-year period ignores everything we know about aluminum chemistry and processing.
This study did not prove a causal relationship between aluminum exposure in vaccines and the development of asthma. Like the Indian folktale about the blind men and the elephant, this study provides one bit of information that needs to be considered in the context of a much larger and more complex system. While more studies will be done to further explore the hypothesis that this study has generated, parents should continue to follow the recommended immunization schedule to protect their children from very real, potentially life-threatening, diseases.
Categories: Parents PACK October 2022
Materials in this section are updated as new information and vaccines become available. The Vaccine Education Center staff regularly reviews materials for accuracy.
You should not consider the information in this site to be specific, professional medical advice for your personal health or for your family's personal health. You should not use it to replace any relationship with a physician or other qualified healthcare professional. For medical concerns, including decisions about vaccinations, medications and other treatments, you should always consult your physician or, in serious cases, seek immediate assistance from emergency personnel.